Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2013

01-02-2013 | Research Article

Perceived medication use challenges and coping strategies among medical outpatients in Nigeria

Author: Kazeem B. Yusuff

Published in: International Journal of Clinical Pharmacy | Issue 1/2013

Login to get access

Abstract

Background The use of medicines is an action that involves a change in behaviour and it is a complex construct involving reciprocal interactions between social, environmental and cognitive factors. This is particularly true when a patient uses medicines for asymptomatic chronic conditions, requiring life-long use. Objective To identify patient-perceived medication use challenges, determine the coping strategies used and investigate the relationship between patient-perceived challenges and self-initiation of coping strategies. Setting A premier 900-bed tertiary/teaching hospital located in Ibadan, Nigeria. Method Ten pharmacists conducted cross-sectional medication use interviews for a random sample of 324 medical outpatients in 4 weeks (25th October–19th November 2006). Main outcome measure Patient-perceived challenges with prescribed medications, self-initiated coping strategies used and relationship between patient-perceived challenges and self-initiation of coping strategies Results Eighty-one percent (324) of the random sample of 400 patients consented and completed the interview. Of these, 50.3 % were males while 49.7 % were females with mean age (SD) of 51.5 (17.6) and 52.1 (17.4) years respectively. The most frequent diagnoses were hypertension (53 %) and type-2 diabetes + hypertension (14.5 %). Two hundred and twenty-four patients reported one or more perceived challenges. Of these, 43.8 % were 65 years or older and about half reported at least 3 challenges. The majority (95.6 %) of patients who reported perceived challenges initiated one or more coping strategies without the knowledge of their physicians or pharmacists. Of 100 patients who did not report any perceived challenge, 43 % admitted initiating strategies to maintain perceived “cure” of their medical conditions. Self-initiation and use of coping strategies was far more likely among patients who reported perceived challenges (OR: 28.4, 95 % CI 26.1–30.5). The number of coping strategies reported appeared strongly related to the number of perceived challenges (r = 0.91, p < 0.001). Conclusion Perceived challenges associated with the use of prescribed medications and self-initiation of coping strategies appeared considerable among medical outpatients at a major teaching hospital in Nigeria. The risk of unauthorised initiation and use of varieties of coping strategies without the knowledge of clinicians was very high among patients who reported at least one perceived challenge.
Literature
1.
go back to reference World Health Organization. Non communicable diseases and mental health adherence to long term therapies project. Adherence to long-term therapies: evidence for action. Geneva: WHO; 2003. p. 110. 1SBN 92 4 154599 2. World Health Organization. Non communicable diseases and mental health adherence to long term therapies project. Adherence to long-term therapies: evidence for action. Geneva: WHO; 2003. p. 110. 1SBN 92 4 154599 2.
2.
go back to reference Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120:1598–605.PubMedCrossRef Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120:1598–605.PubMedCrossRef
3.
go back to reference DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40:794–811.PubMedCrossRef DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40:794–811.PubMedCrossRef
4.
go back to reference Simpson SH, Eurich DT, Majumdar SR, Padual RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;33:15–8.CrossRef Simpson SH, Eurich DT, Majumdar SR, Padual RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;33:15–8.CrossRef
5.
go back to reference Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens. 2006;19(11):1190–6.PubMedCrossRef Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens. 2006;19(11):1190–6.PubMedCrossRef
7.
go back to reference Jokisalo E, Kumpusalo E, Enlund H, Halonen P, Takala J. Factors related to non-compliance with antihypertensive drug therapy. J Hum Hypertens. 2002;6:577–83.CrossRef Jokisalo E, Kumpusalo E, Enlund H, Halonen P, Takala J. Factors related to non-compliance with antihypertensive drug therapy. J Hum Hypertens. 2002;6:577–83.CrossRef
8.
go back to reference Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003;26:1408–12.PubMedCrossRef Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003;26:1408–12.PubMedCrossRef
9.
go back to reference Heisler M, Bouknight RR, Hayward RA, Smith DM, Kerr EA. The relative importance of physician communication, participatory decision making and patient understanding in diabetes self-management. J Gen Intern Med. 2002;17(4):243–52.PubMedCrossRef Heisler M, Bouknight RR, Hayward RA, Smith DM, Kerr EA. The relative importance of physician communication, participatory decision making and patient understanding in diabetes self-management. J Gen Intern Med. 2002;17(4):243–52.PubMedCrossRef
10.
go back to reference Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002;228(19):2469–75.CrossRef Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002;228(19):2469–75.CrossRef
11.
go back to reference Elwyn G, Edwards A, Britten N. “Doing prescribing”: how doctors can be more effective. BMJ. 2003;11:864–7.CrossRef Elwyn G, Edwards A, Britten N. “Doing prescribing”: how doctors can be more effective. BMJ. 2003;11:864–7.CrossRef
12.
go back to reference Cox K, Stevenson F, Britten N, Dundar Y. A systematic review of communication between patients and health care professionals about medicine-taking and prescribing. London: GKT Concordance Unit, King’s College; 2002. Cox K, Stevenson F, Britten N, Dundar Y. A systematic review of communication between patients and health care professionals about medicine-taking and prescribing. London: GKT Concordance Unit, King’s College; 2002.
13.
go back to reference Svensson S, Kjellgren KI, Ahlner J, Säljö R. Reasons for adherence with antihypertensive medication. Int J Cardiol. 2000;76:157–63.PubMedCrossRef Svensson S, Kjellgren KI, Ahlner J, Säljö R. Reasons for adherence with antihypertensive medication. Int J Cardiol. 2000;76:157–63.PubMedCrossRef
14.
go back to reference Rost K, Carter W, Inui T. Introduction of information during the initial medical visit: consequences for patient follow-through with physician recommendations for medication. Soc Sci Med. 1989;28:315–21.PubMedCrossRef Rost K, Carter W, Inui T. Introduction of information during the initial medical visit: consequences for patient follow-through with physician recommendations for medication. Soc Sci Med. 1989;28:315–21.PubMedCrossRef
15.
go back to reference Dowell J, Hudson H. A qualitative study of medicine-taking behaviour in primary care. Fam Pract. 1997;14(5):369–75.PubMedCrossRef Dowell J, Hudson H. A qualitative study of medicine-taking behaviour in primary care. Fam Pract. 1997;14(5):369–75.PubMedCrossRef
16.
go back to reference Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (Or it takes at least two to tango). Soc Sci Med. 1997;44:681–92.PubMedCrossRef Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (Or it takes at least two to tango). Soc Sci Med. 1997;44:681–92.PubMedCrossRef
17.
go back to reference Donovan JL, Blake DR. Patient non-compliance: deviance or reasoned decision-making? Soc Sci Med. 1992;34:507–13.PubMedCrossRef Donovan JL, Blake DR. Patient non-compliance: deviance or reasoned decision-making? Soc Sci Med. 1992;34:507–13.PubMedCrossRef
18.
go back to reference Pollock K, Grime J. Strategies for reducing the prescribing of proton pump inhibitors (PPIs): patient self regulation of treatment may be an under-exploited resource. Soc Sci Med. 2000;51:827–39.CrossRef Pollock K, Grime J. Strategies for reducing the prescribing of proton pump inhibitors (PPIs): patient self regulation of treatment may be an under-exploited resource. Soc Sci Med. 2000;51:827–39.CrossRef
19.
go back to reference Wallenius SH, Vainio KK, Korhonen MJH, Hartzema AG, Enlund HK. Self-initiated modification of hypertension treatment in response to perceived problems. Ann Pharmacother. 1995;29:1213–7.PubMed Wallenius SH, Vainio KK, Korhonen MJH, Hartzema AG, Enlund HK. Self-initiated modification of hypertension treatment in response to perceived problems. Ann Pharmacother. 1995;29:1213–7.PubMed
20.
21.
go back to reference Turk D, Salovey P, Litt M. Adherence: a cognitive-behavioural perspective. In: Gerber K, Nehemkis A, editors. Compliance: the dilemma of the chronically ill. New York: Springer Publishing Co.; 1986. p. 44–72. ISBN 0-. 8771-4208-4. Turk D, Salovey P, Litt M. Adherence: a cognitive-behavioural perspective. In: Gerber K, Nehemkis A, editors. Compliance: the dilemma of the chronically ill. New York: Springer Publishing Co.; 1986. p. 44–72. ISBN 0-. 8771-4208-4.
22.
go back to reference Barber N, Parsons J, Clifford S, Darracott R, Horne R. Patients’ problems with new medication for chronic conditions. Qual Saf Health Care. 2004;13(3):172–5.PubMedCrossRef Barber N, Parsons J, Clifford S, Darracott R, Horne R. Patients’ problems with new medication for chronic conditions. Qual Saf Health Care. 2004;13(3):172–5.PubMedCrossRef
23.
go back to reference Britten N, Ukoumunne O, Boulton MG. Patients’ attitudes to medicines and expectations for prescriptions. Health Expect. 2002;5:256–69.PubMedCrossRef Britten N, Ukoumunne O, Boulton MG. Patients’ attitudes to medicines and expectations for prescriptions. Health Expect. 2002;5:256–69.PubMedCrossRef
24.
go back to reference Bandura A. Social learning theory. Englewood Cliffs: Prentice Hall; 1977. ISBN 013815614X. Bandura A. Social learning theory. Englewood Cliffs: Prentice Hall; 1977. ISBN 013815614X.
26.
go back to reference Skinner BF. Science and human behavior. New York: Macmillan; 1953. ISBN 0 02 929040 6. Skinner BF. Science and human behavior. New York: Macmillan; 1953. ISBN 0 02 929040 6.
27.
go back to reference Enlund HK, Jokisalo E, Wallenius S, Korhonen M. Patient-perceived problems, compliance and the outcome of hypertension treatment. Pharm World Sci. 2001;23(2):60–4.PubMedCrossRef Enlund HK, Jokisalo E, Wallenius S, Korhonen M. Patient-perceived problems, compliance and the outcome of hypertension treatment. Pharm World Sci. 2001;23(2):60–4.PubMedCrossRef
28.
go back to reference Ajayi IO, Olumide EA, Oyediran O. Patient satisfaction with the services provided at a general outpatient clinic, Ibadan, Oyo state, Nigeria. Afr J Med Med Sci. 2005;34:133–40.PubMed Ajayi IO, Olumide EA, Oyediran O. Patient satisfaction with the services provided at a general outpatient clinic, Ibadan, Oyo state, Nigeria. Afr J Med Med Sci. 2005;34:133–40.PubMed
29.
go back to reference Yusuff KB, Obe B, Joseph YB. Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in a Nigerian tertiary care setting. Pharm World Sci. 2008;30:876–83.PubMedCrossRef Yusuff KB, Obe B, Joseph YB. Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in a Nigerian tertiary care setting. Pharm World Sci. 2008;30:876–83.PubMedCrossRef
30.
go back to reference Ernst E. Prevalence of use of complementary/alternative medicine: a systematic review. Bull World Health Organ. 2000;78:252–7.PubMed Ernst E. Prevalence of use of complementary/alternative medicine: a systematic review. Bull World Health Organ. 2000;78:252–7.PubMed
31.
go back to reference Tietzie K. Clinical skills for pharmacists: a patient-focused approach. St Louis: Mosby-year book inc.; 1997. p. 39–40. Tietzie K. Clinical skills for pharmacists: a patient-focused approach. St Louis: Mosby-year book inc.; 1997. p. 39–40.
32.
go back to reference Svarstad BL, Chewining BA, Sleath BL, Claesson C. The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37(2):113–24.PubMedCrossRef Svarstad BL, Chewining BA, Sleath BL, Claesson C. The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37(2):113–24.PubMedCrossRef
33.
go back to reference Lenaghan E, Holland R, Brooks A. Home-based medication review in a high risk elderly population in primary care-the POLYMED randomised controlled trial. Age Ageing. 2007;36:292–7.PubMedCrossRef Lenaghan E, Holland R, Brooks A. Home-based medication review in a high risk elderly population in primary care-the POLYMED randomised controlled trial. Age Ageing. 2007;36:292–7.PubMedCrossRef
34.
go back to reference Ndom RJE, Makanjuola AB. Perceived stress factors among resident doctors in a Nigerian teaching hospital. West Afr J Med. 2004;23(3):78–81. Ndom RJE, Makanjuola AB. Perceived stress factors among resident doctors in a Nigerian teaching hospital. West Afr J Med. 2004;23(3):78–81.
35.
go back to reference Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25:1015–21.PubMedCrossRef Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25:1015–21.PubMedCrossRef
36.
go back to reference Stockl KM, Le L, Zhang S, Harada AS. Clinical and economic outcomes associated with potentially inappropriate prescribing in the elderly. Am J Manag care. 2010;16(1):1–10. Stockl KM, Le L, Zhang S, Harada AS. Clinical and economic outcomes associated with potentially inappropriate prescribing in the elderly. Am J Manag care. 2010;16(1):1–10.
37.
go back to reference Huston PG. Moderating benzodiazepine use in the elderly: curbing physicians prescribing practices. Can Fam Physician. 1992;38:2459–543.PubMed Huston PG. Moderating benzodiazepine use in the elderly: curbing physicians prescribing practices. Can Fam Physician. 1992;38:2459–543.PubMed
38.
go back to reference Hedenmalm K, Spigset O. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur J Clin Pharmacol. 2002;58(4):265–74.PubMedCrossRef Hedenmalm K, Spigset O. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur J Clin Pharmacol. 2002;58(4):265–74.PubMedCrossRef
39.
go back to reference Moorman J. Dipyrone (metamizole) use in the United States: a legal tango. South Med J. 2006;9:916.CrossRef Moorman J. Dipyrone (metamizole) use in the United States: a legal tango. South Med J. 2006;9:916.CrossRef
40.
go back to reference Benjamin SB, Ishak KG, Zimmerman HJ, Grushka A. Phenylbutazone liver injury: a clinical-pathologic survey of 23 cases and review of the literature. Hepatology. 1981;1:255–63.PubMedCrossRef Benjamin SB, Ishak KG, Zimmerman HJ, Grushka A. Phenylbutazone liver injury: a clinical-pathologic survey of 23 cases and review of the literature. Hepatology. 1981;1:255–63.PubMedCrossRef
41.
go back to reference Chaplin S. Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone and chloramphenicol. Adv Drug React Acute Poisoning Rev. 1986;12: 97–136. Chaplin S. Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone and chloramphenicol. Adv Drug React Acute Poisoning Rev. 1986;12: 97–136.
42.
go back to reference Morgan T, Anderson A. The effect of non-steroidal anti-inflammatory drugs on blood pressure in patients treated with different anti-hypertensive drugs. J Clin Hypertens. 2003;5(1):53–7.CrossRef Morgan T, Anderson A. The effect of non-steroidal anti-inflammatory drugs on blood pressure in patients treated with different anti-hypertensive drugs. J Clin Hypertens. 2003;5(1):53–7.CrossRef
43.
go back to reference Polonia J. Interaction of anti-hypertensive drugs with anti-inflammatory drugs. Cardiology. 1997;88(3):47–51.PubMedCrossRef Polonia J. Interaction of anti-hypertensive drugs with anti-inflammatory drugs. Cardiology. 1997;88(3):47–51.PubMedCrossRef
44.
go back to reference Catella-Lawson F, Relly MP, et al. Cyclooxgenase inhibitors and the anti-platelet effects of aspirin. N Engl J Med. 2001;345(25):1809–17.PubMedCrossRef Catella-Lawson F, Relly MP, et al. Cyclooxgenase inhibitors and the anti-platelet effects of aspirin. N Engl J Med. 2001;345(25):1809–17.PubMedCrossRef
45.
go back to reference Macdonald TM, Wei L. Effect of ibuprofen on cardioprotective effect of aspirin. Lancet. 2003;361(9537):573–4.PubMedCrossRef Macdonald TM, Wei L. Effect of ibuprofen on cardioprotective effect of aspirin. Lancet. 2003;361(9537):573–4.PubMedCrossRef
46.
go back to reference Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment. J Amer Med Assoc. 2002;288:2880–3.CrossRef Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment. J Amer Med Assoc. 2002;288:2880–3.CrossRef
47.
go back to reference Jameson JP, VanNoord GR. Pharmacotherapy consultation on polypharmacy patients in ambulatory care. Ann Pharmacother. 2001;35:835–40.PubMedCrossRef Jameson JP, VanNoord GR. Pharmacotherapy consultation on polypharmacy patients in ambulatory care. Ann Pharmacother. 2001;35:835–40.PubMedCrossRef
48.
go back to reference Scarsi KK, Fotis MA, Noskin GA. Pharmacist participation in medical rounds reduces medication errors. Am J Health Syst Pharm. 2002;59:2089–92.PubMed Scarsi KK, Fotis MA, Noskin GA. Pharmacist participation in medical rounds reduces medication errors. Am J Health Syst Pharm. 2002;59:2089–92.PubMed
Metadata
Title
Perceived medication use challenges and coping strategies among medical outpatients in Nigeria
Author
Kazeem B. Yusuff
Publication date
01-02-2013
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 1/2013
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-012-9706-3

Other articles of this Issue 1/2013

International Journal of Clinical Pharmacy 1/2013 Go to the issue